Efficacy of decitabine in advanced chronic myelomonocytic leukemia (CMML) patients

被引：0
|
作者：
Santini, V. [1 ]
Allione, B. [2 ]
Lunghi, M. [3 ]
Levis, A. [4 ]
Poloni, A. [5 ]
Angelucci, E. [6 ]
Onida, F. [7 ,8 ]
Terenzi, A. [9 ]
Finelli, C. [10 ]
Ferrero, D. [2 ]
机构：
[1] AOU Careggi Univ Florence, Hematol, Florence, Italy
[2] Univ Turin, San Giovanni Battista Hosp, Hematol, Turin, Italy
[3] Amedeo Avogadro Univ Eastern Piedmont, Dept Translat Med, Hematol, Novara, Italy
[4] Osped SSAntonio & Biagio, Hematol, Alesssandria, Italy
[5] Univ Ancona Hosp, Hematol, Ancona, Italy
[6] Osped Oncol Armando Businco, Hematol, Cagliari, Italy
[7] IRCCS Fdn Ca Granda, Hematol, Milan, Italy
[8] Univ Milan, Milan, Italy
[9] AO Silvestrini, Oncol & Hematol, Perugia, Italy
[10] Osped S Orsola Malpighi, Ist Seragnoli Hematol, Bologna, Italy
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70040-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-018
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [1] Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML).
    Wijermans, P. W.
    Luebbert, Michael
    Baer, Maria R.
    Slack, James L.
    BLOOD, 2006, 108 (11) : 756A - 757A
  • [2] Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)
    Wijermans, P. W.
    Rueter, B.
    Baer, M. R.
    Slack, J. L.
    Saba, H. I.
    Luebbert, M.
    LEUKEMIA RESEARCH, 2008, 32 (04) : 587 - 591
  • [3] A Phase II Study of Decitabine In Advanced Chronic Myelomonocytic Leukemia (CMML)
    Braun, Thorsten
    Droin, Nathalie
    de Renzis, Benoit
    Dreyfus, Francois
    Laribi, Kamel
    Bouabdallah, Krimo
    Charbonnier, Aude
    Cordonnier, Catherine
    Lafon, Ingrid
    Recher, Christian
    Vey, Norbert
    Bastie, Jean-Noel M.
    Besancon, A.
    Beyne-Rauzy, Odile
    Joly, Bertrand
    Jourdan, Eric
    Legros, Laurence
    Marjanovic, Zora
    Petitdidier, Charlotte
    Royer, Bruno
    Sanhes, Laurence
    Tertian, Gerard
    Vaida, Ioana
    Vallantin, Xavier
    Vekhoff, Anne
    Milic, Marina
    Itzykson, Raphael
    Gardin, Claude
    Ades, Lionel
    Fenaux, Pierre
    Solary, Eric
    BLOOD, 2010, 116 (21) : 780 - 781
  • [4] Decitabine induces high response rates in patients with chronic myelomonocytic leukemia (CMML).
    Jabbour, Elias
    O'Brien, Susan
    Ravandi-Kashani, Farhad
    Cortes, Jorge
    Borthakur, Gautam
    Verstovsek, Srdan
    Garcia-Manero, Guillermo
    Giles, Francis
    Zanoria, Lourdes
    Davisson, Jan
    Issa, Jean-Pierre
    Kantarjian, Hagop M.
    BLOOD, 2006, 108 (11) : 750A - 750A
  • [5] Decitabine In Advanced Chronic Myelomonocytic Leukemia
    Santini, Valeria
    Allione, Bernardino
    Levis, Alessandro
    Gioia, Daniela
    Lunghi, Mania
    Poloni, Antonella
    Cilloni, Daniela
    Zini, Gina
    Sanna, Alessandro
    Rossi, Alessia
    Terenzi, Adelmo
    Angelucci, Emanuele
    Finelli, Carlo
    Onida, Francesco
    Rossi, Giuseppe
    Ferrero, Dario
    Saglio, Giuseppe
    Masiera, Elisa
    BLOOD, 2013, 122 (21)
  • [6] Clinical Efficacy and Safety of Oral Decitabine/Cedazuridine in 133 Patients with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
    Savona, Michael R.
    McCloskey, James K.
    Griffiths, Elizabeth A.
    Yee, Karen W. L.
    Al-Kali, Aref
    Zeidan, Amer M.
    Deeg, H. Joachim
    Patel, Prapti A.
    Sabloff, Mitchell
    Keating, Mary-Margaret
    Kim-Hien Dao
    Zhu, Nancy
    Gabrail, Nashat
    Fazal, Salman
    Maly, Joseph
    Odenike, Olatoyosi
    Kantarjian, Hagop M.
    DeZern, Amy E.
    O'Connell, Casey L.
    Roboz, Gail J.
    Busque, Lambert
    Wells, Richard A.
    Amin, Harshad
    Randhawa, Jasleen K.
    Leber, Brian
    Hao, Yong
    Keer, Harold N.
    Azab, Mohammad
    Garcia-Manero, Guillermo
    BLOOD, 2020, 136
  • [7] Chronic myelomonocytic leukemia (CMML)
    Geissler, Klaus
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2023, 173 (1-2) : 1 - 2
  • [8] Chronic myelomonocytic leukemia (CMML)
    Klaus Geissler
    Wiener Medizinische Wochenschrift, 2023, 173 : 1 - 2
  • [9] CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS WITH LYSOZYME NEPHROPATHY AND CMML RENAL
    Lafargue, Marie-Camille
    Van Huyen, Jean-Paul Duong
    Isnard, Pierre
    Rennke, Helmut
    Essig, Marie
    Carre, Martin
    Mercadal, Lucile
    Farhi, Jonathan
    Bobot, Mickael
    Sakhi, Hamza
    Comont, Thibault
    Golbin, Leonard
    Chemouny, Jonathan
    Cambier, Nathalie
    Laribi, Kamel
    Selamet, Umut
    Riella, Leonardo
    Fain, Olivier
    Ades, Lionel
    Fenaux, Pierre
    Cohen, Camille
    Mekinian, Arsene
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I380 - I381
  • [10] Hypomethylation induction and molecular response after decitabine therapy in chronic myelomonocytic leukemia (CMML).
    Oki, Yasuhiro
    Jelinek, Jaroslav
    Kantarjian, Hagop M.
    Issa, Jean-Pierre J.
    BLOOD, 2006, 108 (11) : 658A - 658A
12345